Lanoxin and Scan abnormal - a phase IV clinical study of FDA data

Summary:

Scan abnormal is reported as a side effect among people who take Lanoxin (digoxin), especially for people who are female, 60+ old, also take Spironolactone, and have Depression.

The phase IV clinical study analyzes which people have Scan abnormal when taking Lanoxin. It is created by eHealthMe based on reports of 21,602 people who have side effects when taking Lanoxin from the FDA, and is updated regularly.

What is Lanoxin?

Lanoxin has active ingredients of digoxin. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 21,852 Lanoxin users. Check the latest studies of Lanoxin.

What is Scan abnormal?

Scan abnormal is found to be associated with 112 drugs and 100 conditions by eHealthMe. Check the latest studies of Scan abnormal.

On Jun, 13, 2026

21,602 people reported to have side effects when taking Lanoxin.
Among them, 20 people (0.09%) have Scan abnormal.

Among these 20 people:

What is the gender of people who have Scan abnormal when taking Lanoxin? *

female: 100 %
male: 0.0 %

What is the age of people who have Scan abnormal when taking Lanoxin? *

What are other drugs people take besides Lanoxin? *

What are other side effects people have besides Scan abnormal? *

X-Ray Abnormal: 20 people, 100.00%
Fall: 20 people, 100.00%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 20 people, 100.00%
Colonoscopy Abnormal: 20 people, 100.00%
Oral Neoplasm Benign (non cancer tumour of mouth): 20 people, 100.00%
Computerised Tomogram Abnormal: 20 people, 100.00%
Cyst (a closed sac): 20 people, 100.00%
Depression: 20 people, 100.00%
Fibrosis (formation of excess fibrous connective tissue in an organ or tissue): 20 people, 100.00%
Inflammation: 20 people, 100.00%

What are the existing conditions these people have? *

Depression: 20 people, 100.00%
Prothrombin Level Abnormal: 14 people, 70.00%
Pain: 14 people, 70.00%
Non-Hodgkin's Lymphoma Stage Iii (malignant (cancer) cells form in the lymph system- stage iii): 14 people, 70.00%

* Approximation only. Some reports may have incomplete information.

Do you take Lanoxin and have Scan abnormal?

- Check whether Scan abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lanoxin:

Lanoxin (21,852 reports)

Scan abnormal treatments and more:

Scan abnormal (426 reports)

Browse all side effects of Lanoxin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Scan abnormal:

Scan abnormal (112 drugs)

Browse all the conditions that are associated with Scan abnormal:

Scan abnormal (100 conditions)

Related publications that referenced our studies

Guru SR, Suresh A, Padmanabhan S, Reddy A, "A Rare Case of Digoxin Associated Gingival Overgrowth", Journal of clinical and diagnostic research: JCDR, 2017 Jan .
Lai SW, Lin CL, Liao KF, "Digoxin use may increase the relative risk of acute pancreatitis: a population-based case–control study in Taiwan", International journal of cardiology, 2015 Feb .
Guru SR, Suresh A, Padmanabhan S, Reddy A, "A Rare Case of Digoxin Associated Gingival Overgrowth", Journal of clinical and diagnostic research: JCDR, 2017 Jan .
Lai SW, Lin CL, Liao KF, "Digoxin use may increase the relative risk of acute pancreatitis: a population-based case–control study in Taiwan", International journal of cardiology, 2015 Feb .

How the study uses the data?

The study uses data from the FDA. It is based on digoxin (the active ingredients of Lanoxin) and Lanoxin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.